Examining the Impact of Rapid Transcranial Magnetic Stimulation (rTMS) on Alleviating Depressive Episodes
Phase 3
- Conditions
- Health Condition 1: F321- Major depressive disorder, singleepisode, moderate
- Registration Number
- CTRI/2024/01/061590
- Lead Sponsor
- KIMS Hubli
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients willing and able to give written informed consent.
Patients of all ages 18 to 60 diagnosed with mild depressive episode and moderate depressive episode for the first time, being treated under psychiatry department KIMS Hubli.
Exclusion Criteria
Patients who refuse to consent for the study
Patients less than 18 years or above 60 years
Patients with severe depressive episode
Medical comorbidities such as epilepsy, vascular, traumatic, tumoral, infectious, or metabolic lesion of the brain, severe or recent heart disease
Pregnancy
Patients who have implanted ferromagnetic devices or other magnetic-sensitive metal
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Remission of Depression will be assessedTimepoint: Remission will be assessed at the end of 5th session and 10th session
- Secondary Outcome Measures
Name Time Method How long the remission lasts will be assessedTimepoint: The patient will be assessed one month after the initial session